Accentuate the negative
Dan has posted previously on how difficult it is for authors to get negative studies published. Perhaps this is the real reason why the STAR*ICU study took 4+ years to make it to press. I suspect that if the study was completed the exact same way that it was but found a benefit for barrier precautions, it would have appeared in press around 2009 or even earlier. Just a guess.
Mike has posted at least twice on Ben Goldacre and his blog/book called Bad Science (part 1 and part 2). Ben has a new post in the Guardian that discusses how medicine, academia and popular culture all favor positive, eye-catching and potentially spurious trial results and ignore important negative studies. His discussion centers around a paper published last year that seemed to provide evidence of precognition - you know it before it actually happens. That "positive" paper received tons of press, while a new negative study can't see the light of day. I think this sort of bias plays a large role in infection prevention research - it is so much easier to publish a positive quasi-experimental study showing a benefit than a negative study. This is why it was so great that after 4+ years of waiting the STAR*ICU study, which was a negative study, was published at the same time as the VA study, which showed a benefit. This way, we could have a rational discussion with the positive/negative evidence receiving "almost" equal billing.
Ben Goldacre "Backwards step on looking into the future" Guardian 4/23/2011
Mike has posted at least twice on Ben Goldacre and his blog/book called Bad Science (part 1 and part 2). Ben has a new post in the Guardian that discusses how medicine, academia and popular culture all favor positive, eye-catching and potentially spurious trial results and ignore important negative studies. His discussion centers around a paper published last year that seemed to provide evidence of precognition - you know it before it actually happens. That "positive" paper received tons of press, while a new negative study can't see the light of day. I think this sort of bias plays a large role in infection prevention research - it is so much easier to publish a positive quasi-experimental study showing a benefit than a negative study. This is why it was so great that after 4+ years of waiting the STAR*ICU study, which was a negative study, was published at the same time as the VA study, which showed a benefit. This way, we could have a rational discussion with the positive/negative evidence receiving "almost" equal billing.
Ben Goldacre "Backwards step on looking into the future" Guardian 4/23/2011
Comments
Post a Comment
Thanks for submitting your comment to the Controversies blog. To reduce spam, all comments will be reviewed by the blog moderator prior to publishing. However, all legitimate comments will be published, whether they agree with or oppose the content of the post.